160 related articles for article (PubMed ID: 23152173)
1. Multiphasic contrast-enhanced MRI: single-slice versus volumetric quantification of tumor enhancement for the assessment of renal clear-cell carcinoma fuhrman grade.
Vargas HA; Delaney HG; Delappe EM; Wang Y; Zheng J; Moskowitz CS; Tan Y; Zhao B; Schwartz LH; Hricak H; Russo P; Akin O
J Magn Reson Imaging; 2013 May; 37(5):1160-7. PubMed ID: 23152173
[TBL] [Abstract][Full Text] [Related]
2. Low enhancement on multiphase contrast-enhanced CT images: an independent predictor of the presence of high tumor grade of clear cell renal cell carcinoma.
Zhu YH; Wang X; Zhang J; Chen YH; Kong W; Huang YR
AJR Am J Roentgenol; 2014 Sep; 203(3):W295-300. PubMed ID: 25148187
[TBL] [Abstract][Full Text] [Related]
3. Performance of Relative Enhancement on Multiphasic MRI for the Differentiation of Clear Cell Renal Cell Carcinoma (RCC) From Papillary and Chromophobe RCC Subtypes and Oncocytoma.
Young JR; Coy H; Kim HJ; Douek M; Lo P; Pantuck AJ; Raman SS
AJR Am J Roentgenol; 2017 Apr; 208(4):812-819. PubMed ID: 28125273
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced magnetic resonance imaging assessment of kidney function and renal masses: single slice versus whole organ/tumor.
Winter KS; Helck AD; Ingrisch M; Staehler M; Stief C; Sommer WH; Braunagel M; Kazmierczak PM; Reiser MF; Nikolaou K; Notohamiprodjo M
Invest Radiol; 2014 Nov; 49(11):720-7. PubMed ID: 24901546
[TBL] [Abstract][Full Text] [Related]
5. Renal masses measuring under 2 cm: pathologic outcomes and associations with MRI features.
Rosenkrantz AB; Wehrli NE; Melamed J; Taneja SS; Shaikh MB
Eur J Radiol; 2014 Aug; 83(8):1311-6. PubMed ID: 24882784
[TBL] [Abstract][Full Text] [Related]
6. Characterization of clear cell renal cell carcinoma with diffusion kurtosis imaging: correlation between diffusion kurtosis parameters and tumor cellularity.
Dai Y; Yao Q; Wu G; Wu D; Wu L; Zhu L; Xue R; Xu J
NMR Biomed; 2016 Jul; 29(7):873-81. PubMed ID: 27119793
[TBL] [Abstract][Full Text] [Related]
7. Role of MR texture analysis in histological subtyping and grading of renal cell carcinoma: a preliminary study.
Goyal A; Razik A; Kandasamy D; Seth A; Das P; Ganeshan B; Sharma R
Abdom Radiol (NY); 2019 Oct; 44(10):3336-3349. PubMed ID: 31300850
[TBL] [Abstract][Full Text] [Related]
8. Statistical clustering of parametric maps from dynamic contrast enhanced MRI and an associated decision tree model for non-invasive tumour grading of T1b solid clear cell renal cell carcinoma.
Xi Y; Yuan Q; Zhang Y; Madhuranthakam AJ; Fulkerson M; Margulis V; Brugarolas J; Kapur P; Cadeddu JA; Pedrosa I
Eur Radiol; 2018 Jan; 28(1):124-132. PubMed ID: 28681074
[TBL] [Abstract][Full Text] [Related]
9. Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon.
Halefoglu AM; Ozagari AA
Radiol Med; 2021 Sep; 126(9):1139-1148. PubMed ID: 34100169
[TBL] [Abstract][Full Text] [Related]
10. Renal cortical tumors: use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes.
Vargas HA; Chaim J; Lefkowitz RA; Lakhman Y; Zheng J; Moskowitz CS; Sohn MJ; Schwartz LH; Russo P; Akin O
Radiology; 2012 Sep; 264(3):779-88. PubMed ID: 22829683
[TBL] [Abstract][Full Text] [Related]
11. Prediction of nuclear grade of clear cell renal cell carcinoma with MRI: intratumoral susceptibility signal intensity versus necrosis.
Chen J; Sun J; Xing W; Ding J; Chen T; Dai Y; Sun J; Hu J
Acta Radiol; 2014 Apr; 55(3):378-84. PubMed ID: 23946232
[TBL] [Abstract][Full Text] [Related]
12. Is there different correlation with prognostic factors between "non-mass" and "mass" type invasive ductal breast cancers?
Jiang L; Zhou Y; Wang Z; Lu X; Chen M; Zhou C
Eur J Radiol; 2013 Sep; 82(9):1404-9. PubMed ID: 23540946
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of Clear Cell Renal Cell Carcinoma From Other Renal Cortical Tumors by Use of a Quantitative Multiparametric MRI Approach.
Hötker AM; Mazaheri Y; Wibmer A; Karlo CA; Zheng J; Moskowitz CS; Tickoo SK; Russo P; Hricak H; Akin O
AJR Am J Roentgenol; 2017 Mar; 208(3):W85-W91. PubMed ID: 28095036
[TBL] [Abstract][Full Text] [Related]
14. Three-dimensional contrast-enhanced hepatic MR imaging: comparison between a centric technique and a linear approach with partial Fourier along both slice and phase directions.
Kim KA; Herigault G; Kim MJ; Chung YE; Hong HS; Choi SY
J Magn Reson Imaging; 2011 Jan; 33(1):160-6. PubMed ID: 21182134
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability.
Braunagel M; Radler E; Ingrisch M; Staehler M; Schmid-Tannwald C; Rist C; Nikolaou K; Reiser MF; Notohamiprodjo M
Invest Radiol; 2015 Jan; 50(1):57-66. PubMed ID: 25260094
[TBL] [Abstract][Full Text] [Related]
16. Can diffusion-weighted magnetic resonance imaging of clear cell renal carcinoma predict low from high nuclear grade tumors.
Parada Villavicencio C; Mc Carthy RJ; Miller FH
Abdom Radiol (NY); 2017 Apr; 42(4):1241-1249. PubMed ID: 27904923
[TBL] [Abstract][Full Text] [Related]
17. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.
Kim JH; Lee JM; Park JH; Kim SC; Joo I; Han JK; Choi BI
Radiology; 2013 Jan; 266(1):185-96. PubMed ID: 23192779
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging volumetric assessment of the extent of contrast enhancement and resection in oligodendroglial tumors.
Sankar T; Moore NZ; Johnson J; Ashby LS; Scheck AC; Shapiro WR; Smith KA; Spetzler RF; Preul MC
J Neurosurg; 2012 Jun; 116(6):1172-81. PubMed ID: 22424566
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Utility of Histogram Apparent Diffusion Coefficient and R2* for Differentiation of Low-Grade From High-Grade Clear Cell Renal Cell Carcinoma.
Zhang YD; Wu CJ; Wang Q; Zhang J; Wang XN; Liu XS; Shi HB
AJR Am J Roentgenol; 2015 Aug; 205(2):W193-201. PubMed ID: 26204307
[TBL] [Abstract][Full Text] [Related]
20. Diffusion-weighted MRI in renal cell carcinoma: a surrogate marker for predicting nuclear grade and histological subtype.
Goyal A; Sharma R; Bhalla AS; Gamanagatti S; Seth A; Iyer VK; Das P
Acta Radiol; 2012 Apr; 53(3):349-58. PubMed ID: 22496427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
